Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001057816 | SCV001222331 | likely benign | Duchenne muscular dystrophy | 2023-11-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003160465 | SCV003868450 | uncertain significance | Cardiovascular phenotype | 2022-12-09 | criteria provided, single submitter | clinical testing | The p.K867E variant (also known as c.2599A>G), located in coding exon 20 of the DMD gene, results from an A to G substitution at nucleotide position 2599. The lysine at codon 867 is replaced by glutamic acid, an amino acid with similar properties. Based on data from gnomAD, the G allele has an overall frequency of 0.0005% (1/183440) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.0012% (1/81885) of European (non-Finnish) alleles. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001836097 | SCV002089706 | uncertain significance | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2018-10-24 | no assertion criteria provided | clinical testing |